Medtronic updates AneuRx system
This article was originally published in The Gray Sheet
Executive Summary
A newer version of Medtronic's AneuRx AAAdvantage abdominal aortic aneurysm (AAA) stent graft with the Xcelerant delivery system wins FDA approval. Updates to the new system include improved radiopaque markers and stent contouring. Roughly 1.2 mil. people in the United States have AAA, though only 15% are ever diagnosed, according to Medtronic. The AneuRx system was originally launched in the U.S. in 1996 (1"The Gray Sheet" Nov. 28, 2005, p. 9)...